Endothelial glycocalyx (EG) is a carbohydrate-rich gel-like mesh covering the apical surface of endothelial cells. It has been linked to the microvascular pathophysiology and tissue metabolism. However, little is known about its condition in young healthy adults.
OBJECTIVE:
We aimed to describe the condition of EG in young healthy adults by in vivo EG imaging and measurement of syndecan-1, a plasma marker of EG integrity in order to obtain reference values.
METHODS:
For in vivo EG studies we used Side-stream Dark Field imaging of the sublingual microcirculation. Recordings were analysed automatically by GlycoCheck software providing the Perfused Boundary Region (PBR) as a marker of EG thickness. Levels of syndecan-1 were analysed in plasma samples by ELISA.
RESULTS:
21 volunteers were included in the study. Median of the PBR value was 1.82 μm (interquartile range 1.69–2.01, 95% CI 1.79–1.97). Median concentration of syndecan-1 was 0.3 ng/ml (interquartile range 0.23–0.39, 95% CI 0.27–0.49).
CONCLUSION:
This study provides a comparison for cohorts of patients with a particular disease where the EG is presumably damaged. Our findings do not entirely comply with already published data in healthy individuals.
CernyV, AstapenkoD, BrettnerF, et al. Targeting the endothelial glycocalyx in acute critical illness as a challenge for clinical and laboratory medicine. Crit Rev Clin Lab Sci. 2017;54(5):343–57.
2.
Krüger-GengeA, BlockiA, FrankeR-P, et al. Vascular endothelial cell biology: An update. Int J Mol Sci. 2019;20(18):4411.
3.
CernyV, AstapenkoD, BurkovskiyI, et al. Glycocalyx in vivo measurement. Clin Hemorheol Microcirc. 2017;67(3–4).
4.
NieuwdorpM, MooijHL, KroonJ, et al. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes. 2006;55(4):1127–32.
5.
MitraR, O’NeilGL, HardingIC, et al. Glycocalyx in atherosclerosis-relevant endothelium function and as a therapeutic target. Curr Atheroscler Rep. 2017;19(12):63.
6.
GoligorskyMS. Vascular endothelium in diabetes. Am J Physiol - Ren Physiol. 2017;312(2):F266–75.
7.
SieveI, Münster-KühnelAK, Hilfiker-KleinerD. Regulation and function of endothelial glycocalyx layer in vascular diseases. Vascul Pharmacol. 2018;100:26–33.
8.
ChappellD, BrueggerD, PotzelJ, et al. Hypervolemia increases release of atrial natriuretic peptide and shedding of the endothelial glycocalyx. Crit Care. 2014;18(5):538.
9.
AstapenkoD, PouskaJ, CernyV, et al. The endothelial glycocalyx and fluid therapy in critical care and perioperative medicine. Anest Intenziv Med. 2017;28(5):289–96.
10.
PouskaJ, TeglV, AstapenkoD, et al. Impact of intravenous fluid challenge infusion time on macrocirculation and endothelial glycocalyx in surgical and critically Ill patients. Biomed Res Int. 2018;2018:1–11.
11.
PouskaJ, AstapenkoD, TeglV, et al. Podání bolusu 500ml fyziologického roztoku nevede k bezprostřednímu poškození endoteliální glykokalyx stanovitelnému hodnocením sublingvální mikrocirkulace. Anest Intensiv Med. 2018;29(6):322–27.
12.
MüllerAM, HermannsMI, CronenC, et al. Comparative study of adhesion molecule expression in cultured human macro- and microvascular endothelial cells. Exp Mol Pathol. 2002;73(3):171–80.
13.
KozarRA, PengZ, ZhangR, et al. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg. 2011;112(6):1289–95.
14.
BrettnerF, DarlingJ, BaeumlE-C, et al. Chances and limitations of isolated mouse heart models for investigating the endothelial glycocalyx1. Clin Hemorheol Microcirc. 2018;69(3):393–403.
15.
LiewH, RobertsMA, MacginleyR, et al. Endothelial glycocalyx in health and kidney disease: Rising star or false Dawn? Summary At a Glance. 2017.
16.
AstapenkoD, PouskaJ, BenesJ, et al. Neuraxial anesthesia is less harmful to the endothelial glycocalyx during elective joint surgery compared to general anesthesia1,2. Clin Hemorheol Microcirc. 2018;1–11.
17.
BelavićM, Sotošek TokmadžićV, FišićE, et al. The effect of various doses of infusion solutions on the endothelial glycocalyx layer in laparoscopic cholecystectomy patients. Minerva Anestesiol. 2018;84(9):1032–43.
18.
NemmeJ, HahnRG, KrizhanovskiiC, et al. Minimal shedding of the glycocalyx layer during abdominal hysterectomy. BMC Anesthesiol. 2017;17(1):107.
19.
PowellM, MathruM, BrandonA, et al. Assessment of endothelial glycocalyx disruption in term parturients receiving a fluid bolus before spinal anesthesia: A prospective observational study. Int J Obstet Anesth. 2014;23(4):330–34.
20.
BrettnerF, ChappellD, NebelsiekT, et al. Preinterventional hydrocortisone sustains the endothelial glycocalyx in cardiac surgery. Clin Hemorheol Microcirc. 2018;1–12.
21.
DaneMJC, KhairounM, LeeDH, et al. Association of kidney function with changes in the endothelial surface layer. Clin J Am Soc Nephrol. 2014;9(4):698–704.
22.
NelsonA, BerkestedtI, SchmidtchenA, et al. Increased levels of glycosaminoglycans during septic shock: Relation to mortality and the antibacterial actions of plasma. Shock. 2008;30(6):623–27.
23.
DonatiA, DamianiE, DomiziR, et al. Alteration of the sublingual microvascular glycocalyx in critically ill patients. Microvasc Res. 2013;90:86–9.
24.
TkachenkoE, RhodesJM, SimonsM. Syndecans: New kids on the signaling block. Circ Res. 2005;96(5):488–500.
25.
LeeDH, DaneMJC, BergBM van den, et al. Deeper penetration of erythrocytes into the endothelial glycocalyx is associated with impaired microvascular perfusion. PLoS One Public Library of Science. 2014;9(5):e96477.
26.
LeeDH, DaneMJC, BergBM van den, et al. Deeper penetration of erythrocytes into the endothelial glycocalyx is associated with impaired microvascular perfusion. PLoS One. 2014;9(5):e96477.
27.
GuY-M, WangS, ZhangL, et al. Characteristics and determinants of the sublingual microcirculation in populations of different ethnicity. Hypertension. 2015;65(5):993–1001.
28.
MyersGJ, WegnerJ. Endothelial glycocalyx and cardiopulmonary bypass. J Extra Corpor Technol. 2017;49(3):174–81.
29.
FerrerNMB, Melo Bezerra CavalcanteCT de, BrancoKMC, et al. Urinary Syndecan-1 and acute kidney injury after pediatric cardiac surgery. Clin Chim Acta. 2018;485:205–09.
30.
Gonzalez RodriguezE, CardenasJC, CoxCS, et al. Traumatic brain injury is associated with increased syndecan-1 shedding in severely injured patients. Scand J Trauma Resusc Emerg Med. 2018;26(1):102.
31.
HahnRG, HasselgrenE, BjörneH, et al. Biomarkers of endothelial injury in plasma are dependent on kidney function. Clin Hemorheol Microcirc. 2019;1–8.
32.
SaboiaZMRM, MenesesGC, MartinsAMC, et al. Association between syndecan-1 and renal function in adolescents with excess weight: Evidence of subclinical kidney disease and endothelial dysfunction. Brazilian J Med Biol Res=Rev Bras Pesqui Medicas e Biol. 2018;51(3):e7174.
33.
KolářováH, AmbrůzováB, Svihálková ŠindlerováL, et al. Modulation of endothelial glycocalyx structure under inflammatory conditions. Mediators Inflamm. 2014;2014:694312.
34.
SubramanianSV, FitzgeraldML, BernfieldM. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem. 1997;272(23):14713–20.
35.
LiJ-P, Kusche-GullbergM. Heparan Sulfate: Biosynthesis, Structure, and Function. In: International review of cell and molecular biology. 2016; bk. 325, pp. 215–73.
36.
LaRivièreWB, SchmidtEP. The Pulmonary Endothelial Glycocalyx in ARDS: A Critical Role for Heparan Sulfate. In: Current topics in membranes. 2018; bk. 82, pp. 33–52.
37.
HuldeN, RogenhoferN, BrettnerF, et al. The CYCLOCALYX study: Ovulatory cycle affects circulating compartments of the endothelial glycocalyx in blood. Am J Reprod Immunol. 2018;79(1):e12767.
38.
IkonomidisI, VoumvourakisA, MakavosG, et al. Association of impaired endothelial glycocalyx with arterial stiffness, coronary microcirculatory dysfunction, and abnormal myocardial deformation in untreated hypertensives. J Clin Hypertens. 2018;20(4):672–79.
39.
MartensRJH, VinkH, OostenbruggeRJ Van, et al. Sublingual microvascular glycocalyx dimensions in lacunar stroke patients. Cerebrovasc Dis. 2013;35(5):451–4.
40.
DaneMJC, KhairounM, LeeDH, et al. Association of kidney function with changes in the endothelial surface layer. Clin J Am Soc Nephrol. 2014;9(4):698–704.
41.
DonatiA, DamianiE, DomiziR, et al. Alteration of the sublingual microvascular glycocalyx in critically ill patients. Microvasc Res. 2013;90:86–9.
42.
Hofmann-KieferKF, KnablJ, MartinoffN, et al. Increased serum concentrations of circulating glycocalyx components in HELLP syndrome compared to healthy pregnancy: An observational study. Reprod Sci. 2013;20(3):318–25.
43.
RehmM, BrueggerD, ChristF, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation. 2007;116(17):1896–906.
44.
NelsonA, BerkestedtI, SchmidtchenA, et al. Increased levels of glycosaminoglycans during septic shock: Relation to mortality and the antibacterial actions of plasma. Shock. 2008;30(6):623–27.
45.
AnttonenA, LeppäS, RuotsalainenT, et al. Pretreatment serum syndecan-1 levels and outcome in small cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer. 2003;41(2):171–7.
